EPISODE · Oct 14, 2024 · 10 MIN
The Effect of Semaglutide on Mortality and COVID-19-Related Deaths - An Analysis From the SELECT Trial
from JACC This Week
In this episode, Dr. Valentin Foster explores the October 2024 issue of JACC, highlighting the significant benefits of semaglutide, particularly for individuals with obesity and cardiovascular disease. He focuses on findings from the SELECT trial, which demonstrate that semaglutide reduces overall and cardiovascular mortality, as well as COVID-19 related deaths, emphasizing the need for continued innovative research in addressing health challenges.
NOW PLAYING
The Effect of Semaglutide on Mortality and COVID-19-Related Deaths - An Analysis From the SELECT Trial
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 3, 2026 ·44m
Feb 21, 2026 ·30m
Jan 2, 2026 ·47m